Evobrutinib clinical trial update: Robert Henderson, Vice President, Global Program Leadership, Neurology & Immunology, Merck Following the conclusion of MSVirtual2020, Merck will be hosting “Mastering the Neuroscience of Unconscious Bias,” the inaugural virtual event for Merck’s I’M IN initiative...
Participants joined weekly sessions via Zoom, filling out the Multiple Sclerosis Self-Efficacy Scale (MSSE), the MS Wellness Questionnaire, and the 36-Item Short Form Survey (SF-36) at the start of the program, as well as at the 6-week mark. While patient evaluations were “glowing,” ...